



Recent studies have shown 
a significant effect on the con-
dition of the pancreas in pa-
tients with primary osteoar-
thritis (OA) [1–3]. It is known 
that the basis of endocrine dis-
orders in chronic pancreatitis 
(CP) is the morphological fea-
tures of the location of the islets 
among the acinar tissue, rather 
than isolated from it, which 
contributes to the interaction 
between exo- and endocrine 
cells of the pancreas [4]. Due 
to the peculiarities of the blood 
supply to the pancreas allocate 
insulo-acinar vascular system. 
In the pancreas, blood f low is 
directed from the islets to the 
exocrine tissue, which is one of 
the bases of functional interac-
tion between the endocrine and 
exocrine tissues, i.e. pancreat-
ic hormones affect its external 
secretion and vice versa [5]. In 
addition, changes in the pan-
creas of patients with CP with 
type 2 diabetes mellitus (DM2) 
often occur against the back-
ground of steatopancreatosis, 
which causes the progression of 
CP and diabetes mellitus [6–8]. 
Thus, the study of the function-
al capacity of the pancreas in 
CP in comorbidity with DM2 
and OA is also relevant given 
that patients with this com-
bination are associated with 
the presence of metabolic syn-
drome [9, 10].
The aim of the study was to 
investigate the state of functional 
capacity of the pancreas in patients with comorbid chronic 
pancreatitis and type 2 diabetes mellitus with osteoarthritis.
2. Material and methods
117 patients with CP with OA with concomitant DM2 and 
without it were studied. The main group consisted of 92 outpa-
tients with CP with OA in combination with diabetes mellitus 
in the phase of stable or unstable remission, the comparison 
group – 25 patients with isolated CP with primary OA, and 
the control group – 30 healthy individuals. The comparison 
groups were comparable in age, sex, duration and treatment 
complex in the previous stages. Patients were registered with 
the Ternopil Center for Primary Health Care and were moni-
tored during 2017–2020. 
The materials of the clinical study were considered at a 
meeting of the commission on bioethics of the I. Horbachevsky 
Ternopil National Medical University Minutes № 60 from 
01.09.2020. The work was carried out in accordance with the 
Code of Ethics of the World Medical Association (Declaration 
of Helsinki). All patients signed an information agreement to 
participate in the study.
The mean age was (47.54± 
±9.51) years. There was a pre-
dominance of women over men 
(59.5 % and 40.5 %), and the 
largest share (72.4 %) were pa-
tients of working age – up to 
65 years. The average duration 
of CP was (11.91±0.97) years, 
OA – (15.24±0.89) years, DM2 – 
(7.56±1.37). Diagnoses of OA, 
CP and DM2 were established 
according to generally accepted 
criteria and protocols [4]. Assess-
ment of the presence and depth 
of excretory insufficiency was 
performed according to the “gold 
standard” – determination of the 
content of fecal α-elastase-1 by 
ELISA using standard kits from 
BIOSERV ELASTASE 1-ELISA. 
The evaluation of parameters 
was performed according to 
generally accepted internation-
al standards (normal pancreas 
function without ECN phenom-
ena – >200 μg/g) [5]. Analysis of 
the coprogram was performed 
to determine the presence of ex-
cretory insufficiency of pancreas 
and concomitant enterocolitis. 
The assessment was performed 
on a scale, where 1 point took 
into account pathological signs. 
To diagnose incretory insuffi-
ciency of the pancreas used to de-
termine the level of fasting blood 
glucose, glycosylated hemoglo-
bin (HbA1c) (using a kit for rapid 
determination of HbA1c by ion 
exchange chromatography) and 
the HOMA-IR index, calculated 
by the formula:
HOMA=(fasting glucose (mmol/l)×
×fasting insulin (μMO/l))/22.5.  (1)
The assessment of the state of the pancreas was performed 
according to the parameters of ultrasound examination of the 
pancreas, which were summarized to determine the severity of 
the process according to the criteria of the Marseille-Cambridge 
classification of CP in points.
The parametric distribution used Student’s t test (t-test). For 
the populations whose distribution differed from the “normal”, 
nonparametric tests were used: to compare two independent 
samples of the Mann-Whitney U-test. Analysis of the relation-
ship between the two traits in the presence of a normal distribu-
tion was evaluated by the results of Pearson’s correlation analy-
sis (r), with a distribution other than normal, a nonparametric 
Spearman’s rank correlation method (R) was used.
3. Results
In the Table 1 presented data on the functional and struc-
tural state of the pancreas in the comparison groups. Analysis 
of the data showed that on average in the contingent of studied 
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patients with comorbid OA, CP and DM2 excretory insufficiency 
of pancreas was significantly more severe than in the group of 
patients with isolated CP with OA on the content of fecal α-elasta- 
se – respectively (109.25±1.21) μg/g and (163.39±3.45) μg/g, 
which corresponded to the medium and mild degrees of ex-
cretory insufficiency of pancreas, respectively, in the groups of 
comorbid with DM2 and isolated CP with OA (p<0.001).
An inexpensive but informative analysis, a coprogram, was 
also used to detect pancreas excretory dysfunction. We found a 
statistically significantly higher level of this indicator in patients 
with CP with DM2 compared with that in isolated CP with OA 
(respectively (5.60±0.10) and (3.89±0.16) points) (p<0.05).
A correlation and regression analysis between faecal α-elas-
tase-1 and glycosylated hemoglobin was also performed, which 
showed the presence of statistically significant high strength of 
negative bonds in both study groups (p<0.05), in the group of pa-
tients with OA and CP without DM2 – r=–0.568, and in the group 
of patients with OA, CP and DM2 – r=–0.791 (p<0.05) (Fig. 1, 2).
Fig. 1. Relationship between fecal α-elastase-1 and glycosylated 
hemoglobin in patients with isolated CP with OA
Analyzing the results of the analysis, it was found that in the 
group of patients with CP and DM2 with OA the correlation was 
statistically significantly stronger than in the group of patients 
with isolated CP, indicating a mutually aggravating effect of CP 
and DM2.
Fig. 2. Relationship between fecal α-elastase-1 and 
glycosylated hemoglobin in patients with CP and DM2 
with OA
4. Discussion 
Many studies have been found to investigate the 
effects of СP on DM2 [6, 7]. Lohr at al. have shown that 
exocrine pancreatic function is associated with incretory 
function of the pancreas [8]. Kothari at al. have shown 
that patients with CP have an increased risk of developing 
DM2 [5]. Many studies have been found on the effect of 
chronic diseases on the course of primary OA [3, 4, 9, 10]. 
However, we did not find any studies that investigated the 
effect of CP and DM2 on the course of primary OA. 
Our data suggest that the comorbid course of CP, 
DM2, and primary OA have a mutually aggravating effect.
Study limitations. A limitation of our study is not 
too many indicators that we studied in the groups of 
patients during treatment and rehabilitation included in 
the study.
Prospects for further research – the development and justi-
fication of comprehensive treatment programs for patients with 
comorbid CP and DM2 with primary OA.
5. Conclusions
1. With the comorbidity of CP and DM2 with OA excretory 
insufficiency of the pancreas was significantly more severe 
than in the group of patients with isolated CP, the content of 
fecal α-elastase – respectively (110.35±1.81) μg/g and (159.56± 
±4.15) μg/g, which corresponded to the average and mild de-
grees of excretory insufficiency pancreas, respectively, and 
the score of the coprogram – respectively (5.60±0.10) and 
(3.89±0.16) points p<0.05).
2. The presence of statistically significant high strength of 
negative relationships between the parameters of fecal α-elas-
tase-1 and glycosylated hemoglobin in both study groups 
(p<0.05): when CP with OA without DM2 – r=–0.568, when 
comorbidity of CP and DM2 – r=–0.791 (p<0.05), which proved 
a significant interaction between the state of excretory and in-
cretory functions of the pancreas.
3. In the combined course of CP and DM2 with OA, the 
correlation between fecal α-elastase-1 and glycosylated hemo-
globin was statistically significantly stronger than in the group 
of patients with isolated CP, indicating a mutually aggravating 
effect of CP and DM2.
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Table 1
Comparative analysis of the functional and structural state of the pancreas 
of patients in the study groups depending on the presence of diabetes 
mellitus type 2







with CP  
(n=25)
Patients with 
CP and DM2 
(n=92)
α-elastase, μg/g 245.63±6.28 163.39±3.45* р2-3<0.05
109.25±1.21**
Blood glucose, mmol/l 4.78±0.08 5.47±0.21* р2-3<0.05
8.91±0.31**
HbA1c, % 4.55±0.10 5.64±0.12* р2-3<0.05
7.75±0.12**
HOMA index 1.46±0.09 1.43±0.07 р2-3<0.05
3.27±0.06**
Coprogram score, points 0.09±0.02 3.69±0.14* р2-3<0.05
5.62±0.11**
Ball ultrasound indicator 
of the structure of the 
pancreas, points
1.05±0.03 3.99±0.68* 6.22±0.66**
Note: * – probable difference of indicators concerning such control groups (p1-2<0.05); 
** – probable difference of indicators in relation to those in the group with isolated 
CP with OA (p1-3<0.05)
 
y = -0,0162x + 8,2462 
















Fecal α-elastase-1, μg/g 
 
y = -0,0733x + 15,798 
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